Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

2010-08-25 01:52:29

Adding cognitive behavioral therapy – an approach that teaches skills for handling life challenges and revising negative thought patterns – to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients.

2010-08-23 07:05:00

NEW YORK, Aug. 23 /PRNewswire/ -- A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes.

2010-08-18 10:00:00

Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed.

2010-08-10 14:50:00

DUBLIN, August 10, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced the divestiture of Daytrana(R) (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc.

2010-07-29 15:30:59

A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents.

2010-07-28 06:00:00

MONMOUTH JUNCTION, N.J., July 28 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved a first-time generic of Methylphenidate Hydrochloride Oral Solution equivalent to brand name Methylin® Oral Solution marketed by Shionogi Pharmaceuticals, Inc. "Tris pursues selective generic opportunities, especially the difficult to formulate or complex formulations and...

2010-07-06 16:00:00

DUBLIN and PHILADELPHIA, July 6 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years.

2010-06-25 07:15:00

MILLER PLACE, N.Y., June 25 /PRNewswire/ -- The Child and Adult Diagnostic and Treatment Program for ADHD, a division of East End Psychological Services, provides testing and state-of-the-art treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan.

2010-06-23 18:51:00

BRENTWOOD, Tenn., June 23 /PRNewswire/ -- Learning Lab, Brentwood will present a free seminar, Does My Child Have ADHD? Diagnosing and What's Next?, on Thursday June 24, 2010 from 7:00-8:00 PM at the Maryland Farms YMCA in Brentwood. The seminar will be presented by Dr.

7913edf43328c6670895a128a70e46031
2010-06-19 07:40:57

A new study published online in the Journal of Pediatrics suggests that neither attention deficit hyperactivity disorder (ADHD) nor medications used to treat it have a long-term impact on kids' growth.


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.